379 related articles for article (PubMed ID: 20360945)
1. The eIF4E/eIF4G interaction inhibitor 4EGI-1 augments TRAIL-mediated apoptosis through c-FLIP Down-regulation and DR5 induction independent of inhibition of cap-dependent protein translation.
Fan S; Li Y; Yue P; Khuri FR; Sun SY
Neoplasia; 2010 Apr; 12(4):346-56. PubMed ID: 20360945
[TBL] [Abstract][Full Text] [Related]
2. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY
Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158
[TBL] [Abstract][Full Text] [Related]
3. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells.
Liu X; Yue P; Chen S; Hu L; Lonial S; Khuri FR; Sun SY
Cancer Res; 2007 May; 67(10):4981-8. PubMed ID: 17510429
[TBL] [Abstract][Full Text] [Related]
4. Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G.
Moerke NJ; Aktas H; Chen H; Cantel S; Reibarkh MY; Fahmy A; Gross JD; Degterev A; Yuan J; Chorev M; Halperin JA; Wagner G
Cell; 2007 Jan; 128(2):257-67. PubMed ID: 17254965
[TBL] [Abstract][Full Text] [Related]
5. 4EGI-1 represses cap-dependent translation and regulates genome-wide translation in malignant pleural mesothelioma.
De A; Jacobson BA; Peterson MS; Jay-Dixon J; Kratzke MG; Sadiq AA; Patel MR; Kratzke RA
Invest New Drugs; 2018 Apr; 36(2):217-229. PubMed ID: 29116477
[TBL] [Abstract][Full Text] [Related]
6. PPARgamma ligands enhance TRAIL-induced apoptosis through DR5 upregulation and c-FLIP downregulation in human lung cancer cells.
Zou W; Liu X; Yue P; Khuri FR; Sun SY
Cancer Biol Ther; 2007 Jan; 6(1):99-106. PubMed ID: 17172826
[TBL] [Abstract][Full Text] [Related]
7. 4EGI-1 induces apoptosis and enhances radiotherapy sensitivity in nasopharyngeal carcinoma cells via DR5 induction on 4E-BP1 dephosphorylation.
Wang W; Li J; Wen Q; Luo J; Chu S; Chen L; Qing Z; Xie G; Xu L; Alnemah MM; Li M; Fan S; Zhang H
Oncotarget; 2016 Apr; 7(16):21728-41. PubMed ID: 26942880
[TBL] [Abstract][Full Text] [Related]
8. Dissecting the roles of DR4, DR5 and c-FLIP in the regulation of geranylgeranyltransferase I inhibition-mediated augmentation of TRAIL-induced apoptosis.
Chen S; Fu L; Raja SM; Yue P; Khuri FR; Sun SY
Mol Cancer; 2010 Jan; 9():23. PubMed ID: 20113484
[TBL] [Abstract][Full Text] [Related]
9. Cellular FLICE-inhibitory protein down-regulation contributes to celecoxib-induced apoptosis in human lung cancer cells.
Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY
Cancer Res; 2006 Dec; 66(23):11115-9. PubMed ID: 17145853
[TBL] [Abstract][Full Text] [Related]
10. 3-substituted indazoles as configurationally locked 4EGI-1 mimetics and inhibitors of the eIF4E/eIF4G interaction.
Yefidoff-Freedman R; Chen T; Sahoo R; Chen L; Wagner G; Halperin JA; Aktas BH; Chorev M
Chembiochem; 2014 Mar; 15(4):595-611. PubMed ID: 24458973
[TBL] [Abstract][Full Text] [Related]
11. Death receptor 5 and cellular FLICE-inhibitory protein regulate pemetrexed-induced apoptosis in human lung cancer cells.
Su L; Liu G; Hao X; Zhong N; Zhong D; Liu X; Singhal S
Eur J Cancer; 2011 Nov; 47(16):2471-8. PubMed ID: 21726997
[TBL] [Abstract][Full Text] [Related]
12. The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor-induced apoptosis.
Raja SM; Chen S; Yue P; Acker TM; Lefkove B; Arbiser JL; Khuri FR; Sun SY
Mol Cancer Ther; 2008 Jul; 7(7):2212-23. PubMed ID: 18645030
[TBL] [Abstract][Full Text] [Related]
13. α-TEA induces apoptosis of human breast cancer cells via activation of TRAIL/DR5 death receptor pathway.
Yu W; Tiwary R; Li J; Park SK; Jia L; Xiong A; Simmons-Menchaca M; Sanders BG; Kline K
Mol Carcinog; 2010 Nov; 49(11):964-73. PubMed ID: 20886583
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
Kim YH; Jung EM; Lee TJ; Kim SH; Choi YH; Park JW; Park JW; Choi KS; Kwon TK
Free Radic Biol Med; 2008 Mar; 44(6):1055-68. PubMed ID: 18164688
[TBL] [Abstract][Full Text] [Related]
15. Involvement of c-FLIP and survivin down-regulation in flexible heteroarotinoid-induced apoptosis and enhancement of TRAIL-initiated apoptosis in lung cancer cells.
Lin Y; Liu X; Yue P; Benbrook DM; Berlin KD; Khuri FR; Sun SY
Mol Cancer Ther; 2008 Nov; 7(11):3556-65. PubMed ID: 19001438
[TBL] [Abstract][Full Text] [Related]
16. Translation of viral mRNAs that do not require eIF4E is blocked by the inhibitor 4EGI-1.
Redondo N; García-Moreno M; Sanz MA; Carrasco L
Virology; 2013 Sep; 444(1-2):171-80. PubMed ID: 23870416
[TBL] [Abstract][Full Text] [Related]
17. SUMO-2 promotes mRNA translation by enhancing interaction between eIF4E and eIF4G.
Chen LZ; Li XY; Huang H; Xing W; Guo W; He J; Sun ZY; Luo AX; Liang HP; Hu J; Wang ZG; Xu YS; Xu X
PLoS One; 2014; 9(6):e100457. PubMed ID: 24971752
[TBL] [Abstract][Full Text] [Related]
18. Cap-translation inhibitor, 4EGI-1, restores sensitivity to ABT-737 apoptosis through cap-dependent and -independent mechanisms in chronic lymphocytic leukemia.
Willimott S; Beck D; Ahearne MJ; Adams VC; Wagner SD
Clin Cancer Res; 2013 Jun; 19(12):3212-23. PubMed ID: 23633452
[TBL] [Abstract][Full Text] [Related]
19. Magnolol Enhances the Therapeutic Effects of TRAIL through DR5 Upregulation and Downregulation of c-FLIP and Mcl-1 Proteins in Cancer Cells.
Woo SM; Min KJ; Kwon TK
Molecules; 2020 Oct; 25(19):. PubMed ID: 33050112
[TBL] [Abstract][Full Text] [Related]
20. Suppression of HSP70 expression sensitizes NSCLC cell lines to TRAIL-induced apoptosis by upregulating DR4 and DR5 and downregulating c-FLIP-L expressions.
Zhuang H; Jiang W; Zhang X; Qiu F; Gan Z; Cheng W; Zhang J; Guan S; Tang B; Huang Q; Wu X; Huang X; Jiang W; Hu Q; Lu M; Hua ZC
J Mol Med (Berl); 2013 Feb; 91(2):219-35. PubMed ID: 22948392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
